01234 269890
01234 271682

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

JUVÉDERM

At Bedford Skin Clinic we use various JUVÉDERM® products for treatment of:

  1.  Smoker’s lines
  2.  Smile lines (These lines – also known as Nasolabial folds – go down from the edge of the nose to the corners of the mouth)
  3.  Lips and philtrum
  4. Accentuation of the eyebrows
  5. Volume enhancement for cheeks, chin, lips and bridge of the nose

The JUVÉDERM® family of hyaluronic acid dermal fillers provides a smooth, long-lasting correction of moderate to severe facial wrinkles and folds. JUVÉDERM® is the first smooth consistency gel formulation and only hyaluronic acid dermal filler approved by the FDA to last up to one year from initial treatment. JUVÉDERM® is developed using the proprietary HYLACROSS™ technology, an advanced manufacturing process that results in a malleable, smooth gel that flows easily and consistently into the skin and provides a predictable result. All other hyaluronic acid dermal fillers currently on the market have a granular consistency gel. These granules can be seen under 2.4x magnification as opposed to the smooth consistency gel of the JUVÉDERM® dermal fillers.

In 2010, the FDA approved JUVÉDERM® XC formulated with the local anaesthetic lidocaine to provide patients with a more comfortable injection experience when compared to the non-lidocaine formulation, and potentially less time spent in the physician’s office. JUVÉDERM® products contain 0.3% preservative-free lidocaine and numb the treatment area within seconds, potentially reducing the need for an additional anaesthetic.

Contraindications: JUVÉDERM® injectable gel should not be used in patients who have severe allergies marked by a history of anaphylaxis or history or presence of multiple severe allergies. JUVÉDERM® should not be used in patients with a history of allergies to Gram-positive bacterial proteins. JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC should not be used in patients with a history of treatment of areas other than facial wrinkles and folds (such as lips) have not been established in controlled clinical studies. Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at injection site. Patients should inform their physician before treatment if they are using these types of substances. As with all skin-injection procedures, there is a risk of infection. JUVÉDERM® should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body’s immune response, as there may be an increased risk of infection. The safety of JUVÉDERM® in patients with a history of excessive scarring (e.g., hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied. If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment with JUVÉDERM® injectable gel, or if JUVÉDERM® is administered before the skin has healed completely after such a procedure, there is a possible risk of an inflammatory reaction at the treatment site.

Adverse events: The side effects include temporary injection-site redness, swelling, pain/tenderness, firmness, lumps/bumps, and bruising. Most side effects are mild or moderate in nature, and their duration is short lasting (7 days or less).

Before and after pictures